SCHEMBL8003046

SCHEMBL8003046

Cn1c(-c2ccccn2)nc(-c2ccc(-c3ccncc3)cc2)c1Sc1ccc(Cl)cn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 10/20 0.56
GRM5 P41594 2/20 0.37
KCNH2 Q12809 2/20 0.36
SLC2A1 P11166 1/20 0.36
CNR1 P21554 1/20 0.36
ACHE P22303 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
MAPK14 Q16539 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12106813 0.91 FAAH (0.54) FAAHGRM5KCNH2SLC2A1CNR1
SCHEMBL1304110 0.91 FAAH (0.55) FAAHGRM5KCNH2SLC2A1CNR1
SCHEMBL8003082 0.86 FAAH (0.51) FAAHGRM5KCNH2SLC2A1CNR1
SCHEMBL1303819 0.85 FAAH (0.50) FAAHGRM5KCNH2CNR1ACHE
SCHEMBL1304003 0.84 FAAH (0.80) FAAHGRM5KCNH2CNR1ACHE
SCHEMBL8008181 0.84 FAAH (0.55) FAAHGRM5KCNH2SLC2A1CNR1
SCHEMBL7993064 0.81 FAAH (0.76) FAAHGRM5KCNH2L3MBTL1LMNA
SCHEMBL8008516 0.78 FAAH (0.71) FAAHGRM5KCNH2L3MBTL1LMNA
SCHEMBL1303678 0.77 FAAH (0.69) FAAHGRM5KCNH2L3MBTL1LMNA
SCHEMBL1303133 0.77 FAAH (0.69) FAAHGRM5KCNH2L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885GRM5 786/4885KCNH2 1076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.